349 related articles for article (PubMed ID: 23942299)
1. Management of sarcomas of the uterus.
Novetsky AP; Powell MA
Curr Opin Oncol; 2013 Sep; 25(5):546-52. PubMed ID: 23942299
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the treatment of sarcomas in gynecology.
Lange SS; Novetsky AP; Powell MA
Discov Med; 2014 Sep; 18(98):133-40. PubMed ID: 25227754
[TBL] [Abstract][Full Text] [Related]
3. Advances in the diagnosis and treatment of uterine sarcomas.
Dizon DS; Birrer MJ
Discov Med; 2014 Jun; 17(96):339-45. PubMed ID: 24979254
[TBL] [Abstract][Full Text] [Related]
4. The management of patients with uterine sarcoma: a debated clinical challenge.
Gadducci A; Cosio S; Romanini A; Genazzani AR
Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy and hormone therapy for uterine sarcomas].
Yamashita H; Arai H; Aoki D
Gan To Kagaku Ryoho; 2012 May; 39(5):722-5. PubMed ID: 22584323
[TBL] [Abstract][Full Text] [Related]
6. Uterine sarcomas--recent progress and future challenges.
Seddon BM; Davda R
Eur J Radiol; 2011 Apr; 78(1):30-40. PubMed ID: 21247711
[TBL] [Abstract][Full Text] [Related]
7. Uterine sarcomas.
Moinfar F; Azodi M; Tavassoli FA
Pathology; 2007 Feb; 39(1):55-71. PubMed ID: 17365823
[TBL] [Abstract][Full Text] [Related]
8. Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas.
Hensley ML
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):773-82. PubMed ID: 21752717
[TBL] [Abstract][Full Text] [Related]
9. Uterine sarcomas: a review.
D'Angelo E; Prat J
Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
[TBL] [Abstract][Full Text] [Related]
10. Uterine sarcomas: then and now.
Shah SH; Jagannathan JP; Krajewski K; O'Regan KN; George S; Ramaiya NH
AJR Am J Roentgenol; 2012 Jul; 199(1):213-23. PubMed ID: 22733915
[TBL] [Abstract][Full Text] [Related]
11. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
[TBL] [Abstract][Full Text] [Related]
12. Update on treatment of uterine sarcoma.
Nam JH; Park JY
Curr Opin Obstet Gynecol; 2010 Feb; 22(1):36-42. PubMed ID: 19923988
[TBL] [Abstract][Full Text] [Related]
13. Uterine sarcoma 2008.
Lin JF; Slomovitz BM
Curr Oncol Rep; 2008 Nov; 10(6):512-8. PubMed ID: 18928666
[TBL] [Abstract][Full Text] [Related]
14. [A clinical analysis of 153 uterine sarcomas].
Bai P; Sun J; Chao H
Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892
[TBL] [Abstract][Full Text] [Related]
15. Systemic treatment in adult uterine sarcomas.
Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
[TBL] [Abstract][Full Text] [Related]
16. [Interdisciplinary S2k guidelines on the diagnosis and treatment of uterine sarcomas-recommendations for surgical pathology].
Horn LC; Höhn AK; Denschlag D; Follmann M; Schmidt D
Pathologe; 2020 Nov; 41(6):621-633. PubMed ID: 32940744
[TBL] [Abstract][Full Text] [Related]
17. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
18. Endometrial stromal sarcoma of uterus.
Xue WC; Cheung AN
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):719-32. PubMed ID: 21820965
[TBL] [Abstract][Full Text] [Related]
19. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
D'Angelo E; Spagnoli LG; Prat J
Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
[TBL] [Abstract][Full Text] [Related]
20. Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments.
Chauveinc L; Deniaud E; Plancher C; Sastre X; Amsani F; de la Rochefordiere A; Rozemberg H; Clough KB
Gynecol Oncol; 1999 Feb; 72(2):232-7. PubMed ID: 10021306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
